Old Web
English
Sign In
Acemap
>
authorDetail
>
Xuemei Guo
Xuemei Guo
Eli Lilly and Company
Molecular biology
Biology
Cancer
Immunology
Cancer cell
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract C129: Antitumor efficacy and non-clinical safety of the high affinity anti-FGFR4 antibody H4: Implications for targeting the FGF19-FGFR4 axis in oncology
2015
Molecular Cancer Therapeutics
Timothy R. Mack
Colleen Burns Burns
Xuemei Guo
William John Feaver
Marie Prewett
Jennifer Gruber
Amelie Forest
Armando R. Irizarry
Ruslan D. Novosiadly
Nick Loizos
Andrew J. Dropsey
Show All
Source
Cite
Save
Citations (0)
Abstract A24: Beta-klotho expression is associated with the antitumor activity of pan-FGFR inhibitor in human malignancies with FGF19 amplification
2015
Molecular Cancer Therapeutics
Amelie Forest
Sandra Nakasone
Ying Wang
Xuemei Guo
Timothy R. Mack
Genshi Zhao
Yong G. Yue
Xueqian Gong
Trent Stewart
Sean Buchanan
Christoph Reinhard
Ruslan D. Novosiadly
Show All
Source
Cite
Save
Citations (0)
1
map